HORVATH SUSAN (V.P. of Finance & CFO) purchased 29.4% of their position (2.50K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a significant purchase.
P · 1 purchase
Filed: 6/9/2020ACC: 0001437749-20-012771
Officer· V.P. of Finance & CFO
Since Dec 2018
+5K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
29.4%
6/5/2020
8.51K→11.01K
Total
Net shares
+2.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2020 | P · Purchase | +2.50K | — | — | 29.4% | 8.51K | 11.01K |
| Total | +2.50K | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
2.50K shares
Shares
+2.50K
Strike price
6
Held after
2.50K
Exercisable
—
6/5/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock2.50K shares | 6/5/2020 | P · Purchase | +2.50K | 6 | — | 2.50K |